Bartlett v. MUTUAL PHARMACEUTICAL CO., INC.’s Empirical Analysis
2009
Citation profile
3 federal appellate · 9 district ·
Relationships
Applies 21 U.S.C. § 301 (Animal Drug Amendments of 1968) · 21 U.S.C. § 321 (Federal Food, Drug, and Cosmetic Act) · 21 U.S.C. § 352 (Federal Food, Drug, and Cosmetic Act) · 21 U.S.C. § 355 (Federal Food, Drug, and Cosmetic Act) · 21 U.S.C. § 356A (Federal Food, Drug, and Cosmetic Act) · 28 U.S.C. § 1332 (Class Action Fairness Act of 2005)
Relies on Skidmore v. Swift & Co. · Auer v. Robbins · Red Lion Broadcasting Co. v. Federal Communications Commission · Florida Lime & Avocado Growers, Inc. v. Paul · Christensen v. Harris County
Most-quoted passages
The sentences later courts lift from this opinion, ranked by how many decisions quote each — the parts of the opinion doing the work. These counts are smaller than the citation total above because most of the 19 citing decisions cite the case generally; a passage count includes only decisions quoting that exact language verbatim.
“the labeling proposed for the new drug is the same as the labeling approved for the [approved brand-name] drug.”
2 later decisions quote this exact passage · from the dissent“introduction into interstate commerce [of] any new drug”
2 later decisions quote this exact passage · from the majority“develop written procedures for the surveillance, receipt, evaluation, and reporting of postmarketing adverse drug experiences to FDA,”
1 later decision quote this exact passage · from the majority
How this case has been treated — in progress
Whether each later court followed, distinguished, criticized, or overruled this decision. The treatment classification (task #35) runs highest-cited cases first and lights up here as it reaches this one.